Table 2.
Insecticide | Location | Time | LC50 (95% FL) (µg mL-1) | Slope ± SE | χ2 | df | P | RR* | DR** | n*** |
---|---|---|---|---|---|---|---|---|---|---|
Methomyl | Lab-PK | 0.06 (0.03-0.17) | 2.56 ± 033 | 9.99 | 6 | 0.12 | 1 | _ | 320 | |
Lahore | Sep. 2008 | 1.31 (0.71-1.91) | 0.81 ± 0.40 | 3.13 | 6 | 0.79 | 21.8 | _ | 320 | |
Mar. 2009 | 1.11 (0.63-1.51) | 0.84 ± 0.26 | 4.61 | 6 | 0.59 | 18.5 | -0.012 | 320 | ||
Sep. 2009 | 0.95 (0.66-1.24) | 1.14 ± 0.23 | 10.5 | 6 | 0.10 | 15.8 | -0.023 | 320 | ||
Mar. 2010 | 0.92 (0.70-1.14) | 1.46 ± 0.28 | 9.23 | 6 | 0.13 | 15.3 | -0.026 | 320 | ||
Sep. 2010 | 1.23 (0.74-1.73) | 0.91 ± 0.33 | 3.69 | 6 | 0.72 | 20.5 | -0.005 | 320 | ||
Faisalabad | Sep. 2008 | 1.33 (0.73-1.94) | 0.83 ± 0.16 | 6.18 | 6 | 0.40 | 22.2 | _ | 320 | |
Mar. 2009 | 1.20 (0.66-1.70) | 0.82 ± 0.24 | 4.18 | 6 | 0.65 | 20 | -0.007 | 320 | ||
Sep. 2009 | 0.99 (0.68-1.31) | 1.11 ± 0.39 | 9.71 | 6 | 0.14 | 16.5 | -0.021 | 320 | ||
Mar. 2010 | 0.94 (0.65-1.22) | 1.13 ± 0.42 | 9.48 | 6 | 0.15 | 15.7 | -0.025 | 320 | ||
Sep. 2010 | 1.23 (0.73-1.72) | 0.91 ± 0.23 | 4.31 | 6 | 0.64 | 20.5 | -0.006 | 320 | ||
Sargodha | Sep. 2008 | 1.01 (0.69-1.32) | 1.14 ± 0.34 | 6.36 | 6 | 0.38 | 16.8 | _ | 320 | |
Mar. 2009 | 0.90 (0.61-1.20) | 1.04 ± 0.22 | 3.26 | 6 | 0.78 | 15 | -0.008 | 320 | ||
Sep. 2009 | 0.80 (0.57-1.03) | 1.18 ± 0.52 | 3.54 | 6 | 0.74 | 13.2 | -0.017 | 320 | ||
Mar. 2010 | 0.92 (0.58-1.26) | 0.92 ± 0.24 | 6.83 | 6 | 0.34 | 15.3 | -0.007 | 320 | ||
Sep. 2010 | 1.10 (0.72-1.47) | 1.06 ± 0.42 | 3.09 | 6 | 0.80 | 18.3 | 0.006 | 320 | ||
Thiodicarb | Lab-PK | 0.03 (0.01-0.11) | 2.28 ± 0.63 | 1.28 | 6 | 0.97 | 1 | _ | 320 | |
Lahore | Sep. 2008 | 1.05 (0.71-1.37) | 1.13 ± 0.23 | 8.29 | 6 | 0.22 | 35 | _ | 320 | |
Mar. 2009 | 0.88 (0.61-1.15) | 1.12 ± 0.32 | 3.99 | 6 | 0.68 | 29.3 | -0.013 | 320 | ||
Sep. 2009 | 0.90 (0.61-1.19) | 1.07 ± 0.41 | 4.49 | 6 | 0.61 | 30 | -0.011 | 320 | ||
Mar. 2010 | 0.71 (0.51-0.89) | 1.28 ± 0.25 | 6.13 | 6 | 0.41 | 23.7 | -0.028 | 320 | ||
Sep. 2010 | 0.99 (0.68-1.28) | 1.17 ± 0.23 | 1.75 | 6 | 0.94 | 33 | -0.004 | 320 | ||
Faisalabad | Sep. 2008 | 1.10 (0.71-1.49) | 1.01 ± 0.28 | 7.92 | 6 | 0.24 | 36.7 | _ | 320 | |
Mar. 2009 | 0.89 (0.63-1.18) | 1.09 ± 0.30 | 5.02 | 6 | 0.54 | 29.7 | -0.015 | 320 | ||
Sep. 2009 | 0.97 (0.62-1.32) | 0.97 ± 0.20 | 4.86 | 6 | 0.56 | 32.3 | -0.009 | 320 | ||
Mar. 2010 | 0.76 (0.54-0.98) | 1.18 ± 0.42 | 8.75 | 6 | 0.19 | 25.3 | -0.027 | 320 | ||
Sep. 2010 | 1.07 (0.71-1.43) | 1.06 ± 0.23 | 4.11 | 6 | 0.66 | 35.7 | -0.002 | 320 | ||
Sargodha | Sep. 2008 | 0.85 (0.52-1.19) | 0.86 ± 0.17 | 5.00 | 6 | 0.54 | 28 | _ | 320 | |
Mar. 2009 | 0.83 (0.58-1.09) | 1.14 ± 0.29 | 1.85 | 6 | 0.93 | 27.7 | -0.002 | 320 | ||
Sep. 2009 | 0.94 (0.63-1.25) | 1.21 ± 0.33 | 4.41 | 6 | 0.62 | 31.2 | 0.007 | 320 | ||
Mar. 2010 | 0.71 (0.53-0.90) | 1.31 ± 0.44 | 6.35 | 6 | 0.39 | 23.7 | -0.013 | 320 | ||
Sep. 2010 | 1.03 (0.71-1.33) | 1.17 ± 0.22 | 3.74 | 6 | 0.71 | 34 | 0.014 | 320 | ||
Indoxacarb | Lab-PK | 0.022 (0.014-0.044) | 2.19 ± 0.46 | 1.73 | 6 | 0.94 | 1 | _ | 320 | |
Lahore | Sep. 2008 | 0.91 (0.59-1.21) | 1.02 ± 0.24 | 3.62 | 6 | 0.73 | 41.4 | _ | 320 | |
Mar. 2009 | 1.29 (0.76-1.83) | 0.90 ± 0.17 | 2.62 | 6 | 0.86 | 58.6 | 0.025 | 320 | ||
Sep. 2009 | 1.12 (0.69-1.54) | 0.95 ± 0.25 | 4.76 | 6 | 0.57 | 50.9 | 0.015 | 320 | ||
Mar. 2010 | 1.18 (0.83-1.52) | 1.28 ± 0.34 | 10.7 | 6 | 0.10 | 53.6 | 0.019 | 320 | ||
Sep. 2010 | 1.19 (0.78-1.59) | 1.07 ± 0.24 | 4.58 | 6 | 0.60 | 54.1 | 0.019 | 320 | ||
Faisalabad | Sep. 2008 | 1.21 (0.64-1.76) | 0.78 ± 0.16 | 3.02 | 6 | 0.81 | 55 | _ | 320 | |
Mar. 2009 | 1.42 (0.78-2.07) | 0.85 ± 0.38 | 4.00 | 6 | 0.68 | 64.5 | 0.012 | 320 | ||
Sep. 2009 | 1.87 (0.66-2.31) | 0.63 ± 0.24 | 1.38 | 6 | 0.97 | 85 | 0.032 | 320 | ||
Mar. 2010 | 1.17 (0.82-1.53) | 1.23 ± 0.43 | 9.78 | 6 | 0.13 | 53.1 | -0.002 | 320 | ||
Sep. 2010 | 2.19 (0.37-4.00) | 0.51 ± 0.11 | 3.19 | 6 | 0.78 | 99.5 | 0.043 | 320 | ||
Sargodha | Sep. 2008 | 1.62 (0.56-2.69) | 0.59 ± 0.18 | 3.77 | 6 | 0.71 | 73.6 | _ | 320 | |
Mar. 2009 | 1.37 (0.73-2.00) | 0.83 ± 0.42 | 1.98 | 5 | 0.85 | 62.3 | -0.012 | 280 | ||
Sep. 2009 | 1.59 (0.78-2.38) | 0.80 ± 0.23 | 3.54 | 6 | 0.74 | 72.3 | -0.001 | 320 | ||
Mar. 2010 | 1.37 (0.77-1.89) | 1.05 ± 0.25 | 12.0 | 6 | 0.07 | 62.2 | -0.012 | 320 | ||
Sep. 2010 | 1.96 (0.60-3.33) | 0.60 ± 0.18 | 3.42 | 6 | 0.75 | 89.1 | 0.014 | 320 | ||
Emamectin benzoate | Lab-PK | 0.09 (0.04-0.14) | 2.35 ± 0.98 | 2.85 | 6 | 0.83 | 1 | _ | 320 | |
Lahore | Sep. 2008 | 1.39 (0.91-1.86) | 1.16 ± 0.26 | 9.23 | 6 | 0.16 | 15.4 | _ | 320 | |
Mar. 2009 | 1.65 (0.59-2.70) | 0.64 ± 0.22 | 0.41 | 4 | 0.98 | 18.3 | 0.013 | 240 | ||
Sep. 2009 | 2.07 (0.60-3.54) | 0.50 ± 0.12 | 7.02 | 6 | 0.32 | 23 | 0.029 | 320 | ||
Mar. 2010 | 1.61 (0.92-2.29) | 1.00 ± 0.27 | 9.62 | 6 | 0.14 | 17.9 | 0.011 | 320 | ||
Sep. 2010 | 2.45 (1.35-4.26) | 0.52 ± 0.26 | 2.66 | 6 | 0.85 | 27.2 | 0.041 | 320 | ||
Faisalabad | Sep. 2008 | 1.35 (0.87-1.82) | 1.10 ± 0.25 | 7.78 | 6 | 0.26 | 15 | _ | 320 | |
Mar. 2009 | 1.97 (1.21-3.32) | 0.61 ± 0.24 | 4.78 | 6 | 0.57 | 21.9 | 0.027 | 320 | ||
Sep. 2009 | 1.47 (0.91-2.02) | 1.07 ± 0.26 | 10.9 | 6 | 0.91 | 16.3 | 0.006 | 320 | ||
Mar. 2010 | 2.00 (1.12-3.17) | 0.76 ± 0.18 | 4.53 | 6 | 0.61 | 22.2 | 0.028 | 320 | ||
Sep. 2010 | 1.89 (0.68-2.50) | 0.65 ± 0.23 | 1.39 | 6 | 0.98 | 21 | 0.024 | 320 | ||
Sargodha | Sep. 2008 | 1.14 (0.85-1.46) | 1.31 ± 0.25 | 7.11 | 6 | 0.31 | 12.7 | _ | 320 | |
Mar. 2009 | 1.26 (0.89-1.63) | 1.33 ± 0.26 | 4.32 | 6 | 0.63 | 14 | 0.007 | 320 | ||
Sep. 2009 | 1.67 (0.88-2.59) | 0.73 ± 0.24 | 5.96 | 6 | 0.43 | 18.6 | 0.028 | 320 | ||
Mar. 2010 | 1.70 (0.86-2.54) | 0.86 ± 0.30 | 7.47 | 5 | 0.19 | 18.9 | 0.029 | 320 | ||
Sep. 2010 | 1.30 (0.91-1.75) | 1.10 ± 0.22 | 3.74 | 6 | 0.71 | 14.4 | 0.010 | 320 | ||
Spinosad | Lab-PK | 0.019 (0.02-0.13) | 2.71 ± 0.44 | 2.92 | 6 | 0.82 | 1 | _ | 320 | |
Lahore | Sep. 2008 | 0.53 (0.40-0.66) | 1.45 ± 0.32 | 3.22 | 6 | 0.78 | 27.9 | _ | 320 | |
Mar. 2009 | 0.51 (0.39-0.61) | 1.78 ± 0.24 | 3.02 | 6 | 0.81 | 26.8 | -0.003 | 320 | ||
Sep. 2009 | 0.48 (0.38-0.57) | 1.09 ± 0.26 | 9.25 | 6 | 0.16 | 25.3 | -0.007 | 320 | ||
Mar. 2010 | 0.57 (0.44-0.69) | 1.56 ± 0.42 | 7.74 | 6 | 0.26 | 30 | 0.005 | 320 | ||
Sep. 2010 | 0.59 (0.43-0.72) | 1.55 ± 0.42 | 10.2 | 6 | 0.13 | 31.1 | 0.008 | 320 | ||
Faisalabad | Sep. 2008 | 0.63 (0.46-0.81) | 1.27 ± 0.23 | 8.32 | 6 | 0.22 | 33.2 | _ | 320 | |
Mar. 2009 | 0.73 (0.55-0.91) | 1.43 ± 0.38 | 5.18 | 6 | 0.52 | 38.4 | 0.011 | 320 | ||
Sep. 2009 | 0.50 (0.38-0.62) | 1.52 ± 0.24 | 10.1 | 6 | 0.12 | 26.3 | -0.012 | 320 | ||
Mar. 2010 | 0.43 (0.30-0.56) | 1.29 ± 0.23 | 12.2 | 6 | 0.06 | 22.6 | -0.028 | 320 | ||
Sep. 2010 | 0.95 (0.70-1.21) | 1.26 ± 0.43 | 2.12 | 6 | 0.91 | 50 | 0.030 | 320 | ||
Sargodha | Sep. 2008 | 0.56 (0.41-0.71) | 1.33 ± 0.22 | 7.79 | 6 | 0.25 | 29.5 | _ | 320 | |
Mar. 2009 | 0.73 (0.54-0.93) | 1.29 ± 0.22 | 4.91 | 6 | 0.56 | 38.4 | 0.019 | 320 | ||
Sep. 2009 | 0.52 (0.39-0.64) | 1.50 ± 0.36 | 10.0 | 6 | 0.16 | 27.4 | -0.005 | 320 | ||
Mar. 2010 | 0.43 (0.29-0.56) | 1.22 ± 0.23 | 9.93 | 6 | 0.13 | 22.6 | -0.019 | 320 | ||
Sep. 2010 | 0.85 (0.62-1.07) | 1.44 ± 0.56 | 3.16 | 6 | 0.79 | 44.7 | 0.030 | 320 |
*Resistance ratio = LC50 field population/LC50 of susceptible strain
**Rate of increase or decrease in resistance *** Number of larvae tested in a bioassay